AffyImmune Therapeutics

Private

Natick, MassachusettsHealthcare & Life Scienceshttps://affyimmune.com

Last Round

Series A

Oct 7, 2021

Total Funding Raised

$38.55M

Company Overview

AffyImmune Therapeutics is a biotechnology company that develops affinity-tuned CAR T cell therapies for the treatment of solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

CAR-T cell therapysolid tumor treatmentaffinity-tuned receptorcell therapyoncologybiotechnologyclinical-stage biotechanaplastic thyroid cancercancer immunotherapyprecision medicinedrug developmentnext-gen CAR-T

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AffyImmune Therapeutics Comps

Public and private peers based on sector, stage, and business model.

AffyImmune Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

AffyImmune Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Oct 7, 2021
Grant	May 25, 2021
Series A	Nov 28, 2018

View all Funding Rounds

Key People

Founding team and executive leadership

Daniel Janse

Chief Executive Officer

Executive Team

AffyImmune Therapeutics Investors

Notable investors and investment history

AffyImmune Therapeutics investors
Investor	Rounds
National Cancer Institute	Grant
Cornell University	Series A
ORI Capital	Series A

View all Investors

AffyImmune Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

AffyImmune Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AffyImmune Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersNatick, Massachusetts

Employee Range5

Year Founded2016

Last FundingOct 7, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.